Nasalcrom duration of use should be focus in labeling, advisory cmte. suggests.
This article was originally published in The Tan Sheet
Executive Summary
NASALCROM DURATION OF USE LABELING INSTRUCTIONS OF PARTICULAR IMPORT for consumers who take the nasal solution for treatment of perennial allergy symptoms, Pulmonary-Allergy Drugs Advisory Committee member John Jenne, MD, stated at an Oct. 10 joint meeting of the Nonprescription Drugs and Pulmonary-Allergy Drugs Advisory Committees in Bethesda, Md. The one-day meeting was held to discuss McNeil's Rx-to-OTC switch application for cromolyn sodium nasal spray. The joint committee recommended approval of the drug for OTC treatment and prevention of allergic rhinitis.